Atlas Trials

Serum Lipoprotein-a as a Marker of Severity of Coronary Artery Disease in Aortic Valve Sclerosis Patients

Clinical trial NCT07209631 · COMPLETED

Trial details

NCT number
NCT07209631
Sponsor
Sohag University
Status
COMPLETED
Study type
OBSERVATIONAL
SerumLipoprotein(A)SeverityCoronary Artery DiseaseAortic Valve Sclerosis
Start date
2024-10-01
Primary completion
2025-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.